| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042800318 |
| P356 | DOI | 10.1186/S12977-015-0218-9 |
| P932 | PMC publication ID | 4636002 |
| P698 | PubMed publication ID | 26545586 |
| P5875 | ResearchGate publication ID | 283576744 |
| P2093 | author name string | Byung Soo Kim | |
| Ji Chang You | |||
| Min-Jung Kim | |||
| Eun Soo Lee | |||
| Soo In Jang | |||
| Kyung Lee Yu | |||
| Seon Hee Kim | |||
| Jung Ae Park | |||
| P2860 | cites work | Inhibition of HIV-1 replication by a bis-thiadiazolbenzene-1,2-diamine that chelates zinc ions from retroviral nucleocapsid zinc fingers | Q24605190 |
| Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles | Q24681117 | ||
| HIV-1 RNA packaging | Q28307322 | ||
| Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins | Q28379468 | ||
| Comparison of the specificity of interaction of cellular and viral zinc-binding domains with 2-mercaptobenzamide thioesters. | Q30356655 | ||
| Topical microbicides: a promising approach for controlling the AIDS pandemic via retroviral zinc finger inhibitors. | Q30366581 | ||
| Identification of HIV-1 nucleocapsid protein: nucleic acid antagonists with cellular anti-HIV activity | Q31107261 | ||
| Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein | Q33436104 | ||
| Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer | Q33720677 | ||
| Identification of HIV-1 inhibitors targeting the nucleocapsid protein. | Q34269543 | ||
| Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication | Q34364648 | ||
| The HIV-1 nucleocapsid zinc finger protein as a target of antiretroviral therapy | Q34373424 | ||
| Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. | Q34418554 | ||
| The determination of importance of sequences neighboring the Psi sequence in lentiviral vector transduction and packaging efficiency | Q34491104 | ||
| Slower uncoating is associated with impaired replicative capability of simian-tropic HIV-1 | Q34965309 | ||
| Single DNA molecule stretching measures the activity of chemicals that target the HIV-1 nucleocapsid protein. | Q35166620 | ||
| In vitro analysis of human immunodeficiency virus particle dissociation: gag proteolytic processing influences dissociation kinetics | Q35184863 | ||
| The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity | Q35834904 | ||
| Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro | Q35854311 | ||
| Development of a cell-based assay probing the specific interaction between the human immunodeficiency virus type 1 nucleocapsid and psi RNA in vivo | Q35857711 | ||
| Intracellular HIV-1 Gag localization is impaired by mutations in the nucleocapsid zinc fingers. | Q35990587 | ||
| Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism | Q36258296 | ||
| A phenyl-thiadiazolylidene-amine derivative ejects zinc from retroviral nucleocapsid zinc fingers and inactivates HIV virions | Q36523852 | ||
| Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein | Q36791433 | ||
| Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus | Q36804927 | ||
| Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. | Q36809360 | ||
| Characterization of antiviral activity of benzamide derivative AH0109 against HIV-1 infection | Q37036503 | ||
| Targeting the viral nucleocapsid protein in anti-HIV-1 therapy. | Q37066805 | ||
| HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro | Q37427179 | ||
| HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. | Q37447762 | ||
| Therapy for HIV: past, present, and future | Q37858308 | ||
| Flexible nature and specific functions of the HIV-1 nucleocapsid protein | Q37901612 | ||
| Comparative nucleic acid chaperone properties of the nucleocapsid protein NCp7 and Tat protein of HIV-1. | Q38022377 | ||
| Anti-HIV drug development: structural features and limitations of present day drugs and future challenges in the successful HIV/AIDS treatment | Q38054847 | ||
| HIV Gag polyprotein: processing and early viral particle assembly | Q38069726 | ||
| Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits | Q38989507 | ||
| Sargassum fusiforme fraction is a potent and specific inhibitor of HIV-1 fusion and reverse transcriptase | Q39341026 | ||
| Identification of the HIV-1 packaging RNA sequence (Ψ) as a major determinant for the translation inhibition conferred by the HIV-1 5' UTR. | Q39429052 | ||
| A time-of-drug addition approach to target identification of antiviral compounds | Q39531429 | ||
| Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication | Q39578721 | ||
| Role of Vif in stability of the human immunodeficiency virus type 1 core | Q39597709 | ||
| Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis | Q39880993 | ||
| Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle | Q40405392 | ||
| Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers. | Q40980778 | ||
| Generation of the replication-competent human immunodeficiency virus type 1 which expresses a jellyfish green fluorescent protein | Q41116485 | ||
| Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. | Q41270026 | ||
| Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds | Q42289296 | ||
| HIV-1 gag proteins: diverse functions in the virus life cycle | Q43783202 | ||
| Benzamide-based thiolcarbamates: a new class of HIV-1 NCp7 inhibitors | Q43891613 | ||
| Cleavage of Gag precursor is required for early replication phase of HIV-1 | Q57178516 | ||
| Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication | Q77362262 | ||
| Mechanistic studies of mini-TAR RNA/DNA annealing in the absence and presence of HIV-1 nucleocapsid protein | Q80234107 | ||
| Structural determinants of HIV-1 nucleocapsid protein for cTAR DNA binding and destabilization, and correlation with inhibition of self-primed DNA synthesis | Q81690042 | ||
| P921 | main subject | viral nucleocapsid | Q4384107 |
| P304 | page(s) | 90 | |
| P577 | publication date | 2015-11-06 | |
| P1433 | published in | Retrovirology | Q15793508 |
| P1476 | title | Identification and characterization of a new type of inhibitor against the human immunodeficiency virus type-1 nucleocapsid protein | |
| P478 | volume | 12 |
| Q40560606 | Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus |
| Q36342362 | Probing Mercaptobenzamides as HIV Inactivators via Nucleocapsid Protein 7. |
| Q52595590 | Understanding of the functional role(s) of the Activating Transcription Factor 4(ATF4) in HIV regulation and production. |
Search more.